1-20 of 22
Reem Karmali
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of prognostic factors in patients with high-risk classical Hodgkin lymphoma undergoing autologous transplantation

Narendranath Epperla, Ying Huang, Amanda F. Cashen, John L. Vaughn, Walter Hanel, Talha Badar, Stefan K. Barta, Paolo F. Caimi, Tarsheen K. Sethi, Nishitha Reddy, Reem Karmali, Celeste Bello, Julio C. Chavez, Shalin K. Kothari, Francisco J. Hernandez-Ilizaliturri, Jakub Svoboda, Frederick Lansigan, Martha J. Glenn, Jonathon B. Cohen, Caryn Sorge, Beth Christian, Alex F. Herrera, Mehdi Hamadani, Luciano J. Costa, Ana C. Xavier
Journal: Blood Advances
Blood Adv (2024) 8 (21): 5458–5466.
https://doi.org/10.1182/bloodadvances.2024013743
Published: 2024
Includes: Supplemental data
Journal Articles

High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series

Narendranath Epperla, Adam S. Zayac, Daniel J. Landsburg, Allison M. Bock, Grzegorz S. Nowakowski, Emily C. Ayers, Mark Girton, Marie Hu, Amy Beckman, Shaoying Li, L. Jeffrey Medeiros, Julie E. Chang, Habibe Kurt, Jose Sandoval-Sus, Mohammad Ali Ansari-Lari, Shalin K. Kothari, Anna Kress, Mina L. Xu, Pallawi Torka, Suchitra Sundaram, Stephen D. Smith, Kikkeri N. Naresh, Yasmin Karimi, David A. Bond, Andrew M. Evens, Seema G. Naik, Manali Kamdar, Bradley M. Haverkos, Reem Karmali, Umar Farooq, Julie M. Vose, Paul Rubinstein, Amina Chaudhry, Adam J. Olszewski
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5355–5364.
https://doi.org/10.1182/bloodadvances.2024013791
Published: 2024
Includes: Supplemental data
Journal Articles

Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy

Clinical Trials & Observations
Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason Romancik, Tamara K. Moyo, Vaishalee Kenkre, Thomas A. Ollila, Lindsey Fitzgerald, Brian Hess, Kevin David, Ishan Roy, Joanna Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul S. Bhansali, Elyse I. Harris, Jieqi Liu, Imran Nizamuddin, Shuo Ma, Jonathan Moreira, Jane Winter, Barbara Pro, Deborah M. Stephens, Alexey Danilov, Nirav N. Shah, Jonathon B. Cohen, Stefan K. Barta, Pallawi Torka, Leo I. Gordon
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2592–2599.
https://doi.org/10.1182/bloodadvances.2023011996
Published: 2024
Journal Articles

Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy

Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason Romancik, Pamela Allen, Tamara K. Moyo, Vaishalee Kenkre, Thomas Ollila, Lindsey Fitzgerald, Brian Hess, Kevin David, Megan M. Herr, Oluwatobi Odetola, Adam Lin, Jonathan Moreira, Shuo Ma, Jane N. Winter, Ishan Roy, Deborah Stephens, Alexey Danilov, Nirav N. Shah, Stefan K. Barta, Matthew Cortese, Jonathon B. Cohen, Leo I. Gordon, Reem Karmali
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2327–2331.
https://doi.org/10.1182/bloodadvances.2024012573
Published: 2024
Journal Articles

A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen

Clinical Trials & Observations
Reem Karmali, Carlos Galvez, Mehdi Hamadani, Leo Gordon, Jane Winter, Shuo Ma, Valerie Nelson, Timothy S. Fenske, Nirav N. Shah, Deepa Jagadeesh, Andreas Klein, Irene Helenowski, Ruohui Chen, Xinlei Mi, Adam Petrich, Andrew M. Evens, Barbara Pro
Journal: Blood Advances
Blood Adv (2024) 8 (7): 1612–1620.
https://doi.org/10.1182/bloodadvances.2023011369
Published: 2024
Includes: Supplemental data
Journal Articles

Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia

Clinical Trials & Observations
Brian T. Hill, Shuo Ma, Clive S. Zent, Andrea M. Baran, Danielle S. Wallace, Anjali Advani, Allison Winter, Jane Winter, Leo Gordan, Reem Karmali, Jane L. Liesveld, Deborah A. Mulford, Chris Rowland, Andrew Bui, Peter Sportelli, Hari P. Miskin, Michael S. Weiss, Jonathan W. Friedberg, Paul M. Barr
Journal: Blood Advances
Blood Adv (2024) 8 (2): 378–387.
https://doi.org/10.1182/bloodadvances.2023010693
Published: 2024
Journal Articles

Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma

James N. Gerson, Elizabeth Handorf, Diego Villa, Alina S. Gerrie, Parv Chapani, Shaoying Li, L. Jeffrey Medeiros, Michael Wang, Jonathon B. Cohen, Michael Churnetski, Brian T. Hill, Yazeed Sawalha, Francisco J. Hernandez-Ilizaliturri, Shalin Kothari, Julie M. Vose, Martin Bast, Timothy Fenske, Swapna Narayana Rao Gari, Kami J. Maddocks, David Bond, Veronika Bachanova, Bhaskar Kolla, Julio Chavez, Bijal Shah, Frederick Lansigan, Timothy Burns, Alexandra M. Donovan, Nina Wagner-Johnston, Marcus Messmer, Amitkumar Mehta, Jennifer K. Anderson, Nishitha Reddy, Alexandra E. Kovach, Daniel J. Landsburg, Martha Glenn, David J. Inwards, Kay Ristow, Reem Karmali, Jason B. Kaplan, Paolo F. Caimi, Saurabh Rajguru, Andrew Evens, Andreas Klein, Elvira Umyarova, Bhargavi Pulluri, Jennifer E. Amengual, Jennifer K. Lue, Catherine Diefenbach, Richard I. Fisher, Stefan K. Barta
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7393–7401.
https://doi.org/10.1182/bloodadvances.2023010757
Published: 2023
Includes: Supplemental data
Journal Articles

Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma

Clinical Trials & Observations
Reem Karmali, Jeremy S. Abramson, Deborah M. Stephens, Jeffrey Barnes, Jane N. Winter, Shuo Ma, Juehua Gao, Jason Kaplan, Adam M. Petrich, Ephraim Hochberg, Tak Takvorian, Xinlei Mi, Valerie Nelson, Leo I. Gordon, Barbara Pro
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7361–7368.
https://doi.org/10.1182/bloodadvances.2023011271
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study

Clinical Trials & Observations
Kaitlin Annunzio, Natalie S. Grover, Rina Li Welkie, Pallawi Torka, Marcus P. Watkins, Andrea Anampa-Guzmán, Montreh Tavakkoli, Timothy S. Oh, Heather Reves, Daniel Jones, Walter Hanel, Beth Christian, Praveen Ramakrishnan Geethakumari, Reem Karmali, Stefan K. Barta, Nancy L. Bartlett, Adam J. Olszewski, Narendranath Epperla
Journal: Blood Advances
Blood Adv (2023) 7 (22): 6839–6843.
https://doi.org/10.1182/bloodadvances.2023011288
Published: 2023
Includes: Supplemental data
Journal Articles

High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study

Clinical Trials & Observations
Adam S. Zayac, Daniel J. Landsburg, Mitchell E. Hughes, Allison M. Bock, Grzegorz S. Nowakowski, Emily C. Ayers, Mark Girton, Marie Hu, Amy K. Beckman, Shaoying Li, L. Jeffrey Medeiros, Julie E. Chang, Adam Stepanovic, Habibe Kurt, Jose Sandoval-Sus, M. Ali Ansari-Lari, Shalin K. Kothari, Anna Kress, Mina L. Xu, Pallawi Torka, Suchitra Sundaram, Stephen D. Smith, Kikkeri N. Naresh, Yasmin H. Karimi, Narendranath Epperla, David A. Bond, Umar Farooq, Mahak Saad, Andrew M. Evens, Karan Pandya, Seema G. Naik, Manali Kamdar, Bradley Haverkos, Reem Karmali, Timothy S. Oh, Julie M. Vose, Heather Nutsch, Paul G. Rubinstein, Amina Chaudhry, Adam J. Olszewski
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6381–6394.
https://doi.org/10.1182/bloodadvances.2023009731
Published: 2023
Includes: Supplemental data
Journal Articles

Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphoma

Clinical Trials & Observations
Jia Ruan, Jasmine Zain, Brett Palmer, Borko Jovanovic, Xinlei Mi, Alok Swaroop, Jane N. Winter, Leo I. Gordon, Reem Karmali, Jonathan Moreira, Adam M. Petrich, Barbara Pro
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5771–5779.
https://doi.org/10.1182/bloodadvances.2023009767
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study

Clinical Trials & Observations
Narendranath Epperla, Qiuhong Zhao, Reem Karmali, Pallawi Torka, Lauren Shea, Timothy S. Oh, Andrea Anampa-Guzmán, Heather Reves, Montreh Tavakkoli, Irl Brian Greenwell, Emily Hansinger, Elvira Umyarova, Kaitlin Annunzio, Yazeed Sawalha, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Nancy L. Bartlett, Natalie S. Grover, Adam J. Olszewski
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5038–5046.
https://doi.org/10.1182/bloodadvances.2023010133
Published: 2023
Includes: Supplemental data
Journal Articles

Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions

Ajay Major, Jovian Yu, Navika Shukla, Yan Che, Theodore G. Karrison, Rachel Treitman, Manali K. Kamdar, Bradley M. Haverkos, James Godfrey, Melissa A. Babcook, Timothy J. Voorhees, Sophie Carlson, Daria Gaut, Caspian Oliai, Jason T. Romancik, Allison M. Winter, Brian T. Hill, Radhika Bansal, Jose C. Villasboas Bisneto, Imran A. Nizamuddin, Reem Karmali, Lindsey A. Fitzgerald, Deborah M. Stephens, Priyanka A. Pophali, Asaad Trabolsi, Jonathan H. Schatz, Marie Hu, Veronika Bachanova, Michael J. Slade, Nathan Singh, Nausheen Ahmed, Joseph P. McGuirk, Michael R. Bishop, Peter A. Riedell, Justin Kline
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4528–4538.
https://doi.org/10.1182/bloodadvances.2023010016
Published: 2023
Includes: Supplemental data
Journal Articles

A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
Geoffrey Shouse, Andy Kaempf, Max J. Gordon, Andy Artz, David Yashar, Audrey M. Sigmund, Gordon Smilnak, Steven M. Bair, Agrima Mian, Lindsey A. Fitzgerald, Amneet Bajwa, Samantha Jaglowski, Neil Bailey, Mazyar Shadman, Krish Patel, Deborah M. Stephens, Manali Kamdar, Brian T. Hill, Jordan Gauthier, Reem Karmali, Loretta J. Nastoupil, Adam S. Kittai, Alexey V. Danilov
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3516–3529.
https://doi.org/10.1182/bloodadvances.2022009309
Published: 2023
Includes: Supplemental data
Journal Articles

A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma

Yazeed Sawalha, Subir Goyal, Jeffrey M. Switchenko, Jason T. Romancik, Manali Kamdar, I. Brian Greenwell, Brian T. Hess, Krista M. Isaac, Craig A. Portell, Alex Mejia Garcia, Scott Goldsmith, Natalie S. Grover, Peter A. Riedell, Reem Karmali, Madelyn Burkart, Michael Buege, Othman Akhtar, Pallawi Torka, Anita Kumar, Brian T. Hill, Brad S. Kahl, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2023) 7 (13): 2983–2993.
https://doi.org/10.1182/bloodadvances.2022008916
Published: 2023
Includes: Supplemental data
Journal Articles

Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma

Clinical Trials & Observations
Pamela B. Allen, Xinyan Lu, Qing Chen, Kaitlyn O’Shea, Joan S. Chmiel, Liron Barnea Slonim, Madina Sukhanova, Hatice Savas, Andrew M. Evens, Ranjana Advani, Barbara Pro, Reem Karmali, Brett Palmer, Robert A. Bayer, Robert M. Eisner, Eric Mou, Gary Dillehay, Leo I. Gordon, Jane N. Winter
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2670–2676.
https://doi.org/10.1182/bloodadvances.2022008116
Published: 2023
Journal Articles

Peri–CAR-T practice patterns and survival predictors for all CAR-T patients and post–CAR-T failure in aggressive B-NHL

Clinical Trials & Observations
Joanna Zurko, Imran Nizamuddin, Narendranath Epperla, Kevin David, Jonathon B. Cohen, Tamara K. Moyo, Thomas Ollila, Brian Hess, Ishan Roy, Robert Ferdman, Jieqi Liu, Sayan Mullick Chowdhury, Jason Romancik, Rahul S. Bhansali, Elyse I. Harris, Mckenzie Sorrell, Rebecca Masel, Adam S. Kittai, Nathan Denlinger, Audrey M. Sigmund, Lindsey Fitzgerald, Carlos Galvez, Shuo Ma, Jane Winter, Barbara Pro, Leo I. Gordon, Alexey Danilov, Deborah Stephens, Nirav N. Shah, Vaishalee Kenkre, Stefan K. Barta, Pallawi Torka, Geoffrey Shouse, Reem Karmali
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2657–2669.
https://doi.org/10.1182/bloodadvances.2022008240
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Clinical Trials & Observations
Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Max J. Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T. Hill, Nilanjan Ghosh, Steven I. Park, David A. Bond, Mehdi Hamadani, Timothy S. Fenske, Peter Martin, Mary-Kate Malecek, Brad S. Kahl, Christopher R. Flowers, Brian K. Link, Lawrence D. Kaplan, David J. Inwards, Andrew L. Feldman, Eric D. Hsi, Kami Maddocks, Kristie A. Blum, Nancy L. Bartlett, James R. Cerhan, John P. Leonard, Thomas M. Habermann, Matthew J. Maurer, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2287–2296.
https://doi.org/10.1182/bloodadvances.2022009225
Published: 2023
Includes: Supplemental data
Journal Articles

Postibrutinib relapse outcomes for patients with marginal zone lymphoma

Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara K. Moyo, Nishitha Reddy, Julia Sheets, David M. Weiner, Praveen Ramakrishnan Geethakumari, Malathi Kandarpa, Ximena Jordan Bruno, Colin Thomas, Michael C. Churnetski, Andrew Hsu, Luke Zurbriggen, Xiao-wei Cherie Tan, Kathryn Lindsey, Joseph Maakaron, Paolo F. Caimi, Pallawi Torka, Celeste Bello, Sabarish Ayyappan, Timothy S. Oh, Reem Karmali, Seo-Hyun Kim, Anna Kress, Shalin Kothari, Yazeed Sawalha, Beth Christian, Kevin A. David, Irl Brian Greenwell, Murali Janakiram, Vaishalee P. Kenkre, Adam J. Olszewski, Jonathon B. Cohen, Neil Palmisiano, Elvira Umyarova, Ryan A. Wilcox, Farrukh T. Awan, Juan Pablo Alderuccio, Stefan K. Barta, Natalie S. Grover, Nilanjan Ghosh, Nancy L. Bartlett, Alex F. Herrera, Geoffrey Shouse
Journal: Blood Advances
Blood Adv (2023) 7 (1): 88–91.
https://doi.org/10.1182/bloodadvances.2022008634
Published: 2023
Includes: Supplemental data
Journal Articles

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

Clinical Trials & Observations
David A. Bond, Jeffrey M. Switchenko, Diego Villa, Kami Maddocks, Michael Churnetski, Alina S. Gerrie, Subir Goyal, Krithika Shanmugasundaram, Oscar Calzada, Bhaskar Kolla, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Brian T. Hill, Yazeed Sawalha, Peter Martin, Edward Maldonado, Max Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Nilanjan Ghosh, Steven I. Park, Narendranath Epperla, Talha Badar, Jin Guo, Mehdi Hamadani, Timothy S. Fenske, Mary-Kate Malecek, Brad S. Kahl, Christopher R. Flowers, Kristie A. Blum, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5179–5189.
https://doi.org/10.1182/bloodadvances.2021004765
Published: 2021
Includes: Supplemental data